Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affimed, Artiva, Astrazeneca, Bioarctic, Eisai, Genentech, Iliad, Merus, Mesoblast, Mind Medicine, Neuraxpharm, Nobias , Phanes, Roche.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Nano-x, Tyber.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allay, Biocardia, Biopharmaceutical Research, Leo, Outlook, Simcere, Stoke.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Centerline Biomedical, Lifesignals, Lungpacer Medical, Magstim, Nano-X Imaging.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvogene, Corbus, Exegenesis, Hutchmed, Innovent, Intra-cellular, Lantern, Merck, PIF, Rezolute, Rhythm, Saol.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carlsmed, Rhein Laser, Zimmer Biomet.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aavantgarde, Applied Therapeutics, Biocon, Bluebird, Cytokinetics, Everest Medicines, Johnson & Johnson, Pfizer, PTC, Rigel, Sana, Stallergenes, Travere.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beacon Biosignals, GE Healthcare, Matortho, Nonin Medical, Screenpoint Medical, Wave Neuroscience.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Beigene, Kelun-Biotech.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advanz, Anavex, Aop Orphan, Beigene, Cevomed, Exelixis, Gsk, Kelun-Biotech, Lin, Novartis, Oncopeptides, Satsuma, Tuhura, Valneva.